The largest database of trusted experimental protocols

5 protocols using matrigel

1

Cardiac Progenitor Differentiation from hPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human LQTS iPSCs (iPSCORE_2_145 (link)) and human ESCs (H1 and H946 (link)) were maintained on Matrigel (Corning)-coated surfaces in mTeSR1 (STEMCELL Technologies) as previously decribed47 (link). Cardiac progenitor differentiation was performed as described previously22 . Briefly, hPSCs were singularized with Accutase (Thermo Fisher Scientific) and plated onto Matrigel-coated plates at a density of 3.0×105 cells/cm2 in mTeSR1 supplemented with 10 μM Rho-associated protein kinase (ROCK) inhibitor Y-27632 (Selleckchem) on day −2. The differentiation was initiated with Wnt activation by 8 μM CHIR99021 (Selleckchem) on day 0 and sequential Wnt inhibition by 5μM IPW2 on day 3. Cardiac progenitors were ready on day 6 for CS generation.
+ Open protocol
+ Expand
2

Differentiation of H9 ESCs to NPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
H9-ESCs were induced to differentiate into H9–NPSCs as previous reported [23 (link)]. Briefly, H9-ESCs cultured in E8 medium were passaged in a six well plate coated with Matrigel (BD Biosciences, USA). H9-ESCs at about 30% confluency were cultured in basic medium containing 1 μM compound C (Selleck, USA). After three days, 100 nM retinoic acid was added to the basic medium. After another three days, 100 ng/mL SHH and 100 nM retinoic acid were both added to the basic medium without compound C. After another three days of differentiation, H9-ESCs had almost differentiated into H9–NSPCs. Basic medium was composed of 50% Advanced DMEM/F12 (Invitrogen, USA), 50% Neurobasal (Gibco, USA), 1 × N2 (Gibco, USA), 1 × B27 (Gibco, USA), 1% GlutaMAX (Gibco, USA), 1% NEAA (Gibco, USA), 1% penicillin-streptomycin (Gibco, USA). H9–NSPCs were then cultured on plates coated with Matrigel in basic medium containing 100 nM retinoic acid (Selleck, USA) and 0.5 μM small purmorphamine (Selleck, USA).
+ Open protocol
+ Expand
3

Cell Line Culture and Lentiviral Transduction

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cell lines were cultured at 37°C with 5% CO2 in tissue culture incubators. HEK293T (female), HeLa (female), and U2OS (female) cells were cultured in Dulbecco’s modified eagle medium (DMEM) in 10% FBS (HyClone or VWR), 100 units/mL streptomycin, 100 μg/ml penicillin, and 2 mM glutamine. K562 (female) cells were maintained in RPMI-1640 with 25 mM HEPES and 2.0 g/L NaHCo3 in 10% FBS, 2 mM glutamine, 100 units/mL streptomycin, and 100 mg/mL penicillin. WTC Gen1c iPSCs (male) were cultured in mTESR media (STEMCELL Technologies) under feeder-free conditions on growth factor-reduced Matrigel (BD Biosciences). Cells were passaged using Accutase (STEMCELL Technologies) and seeded on Matrigel coated plates with mTESR media supplemented with p16-Rho-associated coiled-coil kinase (ROCK) inhibitor Y-27632 (10 μM; Selleckchem).
Lentiviral particles were produced by transfecting standard packaging vectors into HEK293T using TransIT-LT1 Transfection Reagent (Mirus, MIR2306). Media was changed 24 hours post-transfection with complete DMEM supplemented with 15 mM HEPES. Viral supernatants were harvested 48–60 hours after transfection and filtered through a 0.45 μm PVDF syringe filter. Lentiviral infections included polybrene (8 μg/ml).
+ Open protocol
+ Expand
4

Invasion Assay for Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
The invasion assay was conducted using a 24-well trans-well chamber with a polycarbonate membrane with a pore size of 8 μm (Corning, NY, USA). The membrane was coated with 60 μL of 17% Matrigel (BD Sciences, San Jose, CA, USA) and serum-free RPMI 1640 medium to form a matrix barrier. After the Matrigel was allowed to solidify at 37 °C for 2 h, 22Rv1 and LNCaP cells (100,000 cells/mL, treated with mitomycin C (10 μg/mL, Selleck, Houston, TX, USA) 2 h for inhibiting cell proliferation) that had or had not been co-cultured with M2 macrophage were added to the upper compartment of the chamber; the lower chamber was filled with 0.6 mL of medium supplemented with 10% FBS as a chemoattractant. After incubation at 37 °C for 24 h, Matrigel and the cells remaining in the upper chamber were removed using cotton swabs. Cells on the lower surface of the membrane were fixed in 4% paraformaldehyde and stained with Giemsa (Solarbio, Beijing, China). Cells in 3 microscopic fields were counted and photographed. All experiments were performed in triplicate.
+ Open protocol
+ Expand
5

Routine Culture and Maintenance of hPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For routine culture and maintenance, hESC lines (H9 and H1, WiCell) and iPSC lines (TMOi001-A, ThermoFisher) were grown on Matrigel (Corning, lot #1313001) coated plates in mTeSR1 medium (STEMCELL Technologies) and 1% penicillin/streptomycin (Life Technologies) at 37°C and 5% CO2 with daily media changes. For single-cell seeded maintenance or experiments, cells were singularized with Accutase (STEMCELL Technologies) at 37°C for 4 min and seeded onto Matrigel-coated plates in media containing 10 μM ROCK inhibitor Y-27632 (Selleckchem). 6-well plates were utilized for hPSC maintenance while hPSC differentiations were performed on 24-well plates for the 2D conditions. Cells were seeded at a density of 15k cell/cm2 for maintenance or 35k cells/cm2 for differentiations (see hPSC differentiation in 2D). For cluster seeded maintenance or experiments, hESCs were collected with Versene (ThermoFisher) at 37°C for 4 min and were dissociated with a P1000 wide bore pipette (ThermoFisher). Maintenance passages ranged from 1:10-1:12 (∼15k cells/cm2). Cell counts were determined by further trituration and counting on a hemocytometer.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!